Skip to main content
Clinical Trials/IRCT20220316054311N1
IRCT20220316054311N1RecruitingPhase 3

The effect of dexmedetomidine on hemodynamic changes in patients undergoing coronary artery bypass graft

Vice-Chancellery for Research Hormozgan University of Medical Sciences0 sites72 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
Enrollment
72

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30 years to 80 years (—)
Sex
All

Inclusion Criteria

  • Age 30-80 years
  • American Society of Anesthesiologists (ASA) class II, III, and IV
  • Candidates of elective coronary artery bypass graft (CABG) with cardiopulmonary bypass (CPB)

Exclusion Criteria

  • Emergency surgery
  • Ejection fraction <30%
  • Concurrent valvular sugery
  • Any complication during surgery and pacemaker requirement

Investigators

Sponsor
Vice-Chancellery for Research Hormozgan University of Medical Sciences

Similar Trials